Skip to main content
NewslettersWatchlist

Helix Biopharm(HBP-T)
TSX

Today's Change
Real-Time Last Update

Helix Biopharm

401 Bay Street
Suite 2704
Toronto ON M5H 2Y CAN
P: 905-841-2300
F: 905-841-2244
https://www.helixbiopharma.com

Sectors & Indices

Sector
Industry
Employees

    Profile

    Helix BioPharma Corp is a clinical-stage biopharmaceutical company. It is focused on cancer drug development. The company develops therapies in the field of immuno-oncology based on its proprietary technology mainly in the areas of cancer prevention and treatment. Its pipeline candidates are Tumor Defence Breaker L-DOS47, and, V-DOS47 among others.

    Key Executives

    NameTitle
    Hatem KawarCFO
    Jacek AntasCEO/Chairman of the Board/Director
    Namrata MalhotraSecretary
    Frank Gary RenshawChief Medical Officer
    Christof BoehlerOther Executive Officer
    Srikanth SolaChief Strategy Officer

    More from The Globe

    The close: Stocks higher as investors focus on Fed moves
    Traders work on the floor at the New York Stock Exchange (NYSE) in New York City, U.S., April 26.
    The close: Major North American indexes rise as megacap tech stocks rally
    A trader works on the floor at the New York Stock Exchange (NYSE) on April 25.
    Why this money manager is venturing back into emerging markets and adding more U.S. tech
    Illustration of Andrew Pyle for The Mover. Nov. 5, 2022. Illustration by Joel Kimmel
    How a Canadian pirate-clad pastor helped ignite Trump Media’s market frenzy
    Former President Donald Trump sits in Manhattan Criminal Court in New York, Thursday, April 25.
    Activist investor targets Dye & Durham’s ‘underperformance and strategic missteps’ in letter to shareholders
    Dye & Durham Ltd. says it has launched a strategic review of its non-core assets in an effort to reduce its debt. The logo for Dye & Durham Ltd. is shown in this undated handout photo. THE CANADIAN PRESS/HO
    The close: U.S. stocks fall as GDP report spreads rate-cut gloom; Alphabet surges 15% in post market
    Traders work on the floor of the New York Stock Exchange shortly after the opening bell, Wednesday, April 24.
    Fiera Capital’s largest shareholder looks to sell stake in company
    Jean-Guy Desjardins, global CEO and founder of Fire Capital posses for a portrait at Fiera Capital, in Montreal on Monday, January 8, 2024. Evan Buhler/The Globe and Mail�
    The close: S&P 500 higher as markets weigh rising bond yields and upbeat U.S. earnings; TSX lower as rails slide
    The Art Deco facade of the original Toronto Stock Exchange building is seen on Bay Street in Toronto in January of 2019.

    All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2024.

    Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

    Financial data provided by Zacks Investment Research.